SC Alvogen Romania SRL

032266 Bucharest
44B Theodor Pallady Boulevard
3rd district

+4 021 351 02 86
+4 021 351 02 90

Alvogen announced its expansion in Romania in January 2010, by opening an office in Bucharest. Market focus is on sales and marketing of a fast growing product pipeline. The office also employed regulatory and pharmacovigilance experts.

Viorica Preduna is the Country Manager of Alvogen Romania, leading a team of approximately 30 employees, so far.

The well-established Romanian pharmaceutical market generates annual sales totaling $3 billion and Alvogen believes the market will experience solid growth as the Romanian healthcare infrastructure improves.

“We see great opportunities for our business in Eastern Europe and we are gradually building up our portfolio and market reach. Through registration of our own products, portfolio acquisitions and strategic partnerships, we aim to build a strong presence in the market with targeted product offering”, said Laurentiu Scheusan, EVP of Sales & Marketing in the CEE region.

Market Info

In Romania, the generics market is expected to grow 35% by 2015, to approx. $1.1 billion, due to legislative measures assumed regarding the compensation of medicines, to new product launchings and to popularization of the generic medicines.

Analysts estimate a volume growth of the pharmaceutical market, in general, of 5-8% per year until 2015, but the generic medicines market is expected to grow faster, according to the Association of Generic Medicines Manufacturers from Romania (APMGR).

  • $2.6BRomanian pharmaceutical
    market in first
    9 months of 2011
  • 8.4%Generics market growth
    in value (first 9
    months of 2011)
  • 7.9%Branded generics market
    growth in value
    (first 9 months of 2011)
  • 35%Generics market
    growth by 2015

Say Hello to Romania